期刊文献+

干扰素-γ增强肝癌细胞对CTL杀伤敏感性的研究

Study on the susceptibility of the hepatocarcinoma cell to DC-derived CTL lysis under the stimulation of interferon-γ
下载PDF
导出
摘要 目的:探讨干扰素-γ(interferon-γ,IFN-γ)能否增强肝癌细胞对树突状细胞(dendritic cell,DC)诱导细胞毒T淋巴细胞(cytotoxic T lymphocyte,CTL)杀伤的敏感性,以及该作用与肿瘤细胞HLAⅠ类分子的关系。方法:RT-PCR法检测IFN-γ刺激前后肝癌细胞β2-微球蛋白(β2-microgloblin,β2-m)的mRNA水平变化,流式细胞术检测肝癌细胞HLAⅠ类分子HLA-A2的表达;应用脐血来源的致敏DC诱导CTL细胞毒试验,观察IFN-γ在增强肝癌细胞对特异性CTL杀伤作用敏感性中的作用。结果:IFN-γ可刺激肝癌细胞上调β2-mmRNA水平及细胞表面HLA-A2表达,IFN-γ作用48h后肝癌细胞β2-m mRNA相对光密度值(1.104±0.209)与0h组(0.674±0.135)比较显著增加,t=-2.992,P=0.040。在72和96h仍保持较高水平,其HLA-A2表达增加的幅度与β2-m一致;致敏的脐血来源DC能够在体外诱导CTL特异性地杀伤肝癌细胞,经IFN-γ刺激的肝癌细胞对特异性效应细胞杀伤作用的敏感性显著增强。结论:IFN-γ可使肝癌细胞对DC诱导的CTL杀伤效应的敏感性增加,可能与其上调肝癌细胞β2-m mRNA水平进而增加HLAⅠ类分子的表达有关。 OBJECTIVE:To study whether interferon-γ can enhance the specific CTL lysis of the tumor cells and its effect on the HLA-I molecules of the tumor cells. METHODS: The mRNA level of β2-microgloblin(β2-m) in the tumor cell were detected by RT-PCR. The expression of HLA-A2 on the tumor cells were detected by flow cytometry. Lymphocytes were primed by DCs, which were derived from cord blood and pulsed with whole tumor cell lysates. The susceptibility of the hepatocarcinoma cell to CTL lysis under the stimulation ...
出处 《中华肿瘤防治杂志》 CAS 2008年第9期668-671,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 天津市科委攻关项目基金(05YFSZSF02500) 天津市人工细胞重点实验室建设基金(05SYSYJC02600)
关键词 干扰素-Γ 肝细胞 Β2-微球蛋白 树突状细胞 细胞毒T淋巴细胞 interferon-γ carcinoma hepatocellular β2-microgloblin dendritic cell cytotoxic T cell
  • 相关文献

参考文献4

二级参考文献15

  • 1杜智,高英堂,阚学锋,王毅军,景丽,朱争艳,经翔.肝癌分子边界的初步实验研究[J].生物医学工程与临床,2005,9(4):232-236. 被引量:4
  • 2Kang Sun,Liang Wang,Yanyun Zhang.Dendritic Cell as Therapeutic Vaccines against Tumors and Its Role in Therapy for Hepatocellular Carcinoma[J].Cellular & Molecular Immunology,2006,3(3):197-203. 被引量:22
  • 3叶红军,太京华,姜英,孙述臣,肖红.原发性肝癌患者的干扰素、细胞毒性因子和肿瘤坏死因子的观察[J].临床肝胆病杂志,1997,13(2):83-84. 被引量:2
  • 4Ferrone S, Marincola FM. Loss of HLA class Ⅰ antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance[J]. Immunol Today, 1995,16(10):487
  • 5D'Urso CM, Wang Z, Cao Y, et al. Lack of HLA class Ⅰ antigen expression by cultured melanoma cells FO-1 due to a defect in beta2-microgoblin gene expression[J]. J Clin Invest, 1991,87(1):284
  • 6Atkins D, Ferrone S, Schmahl GE, et al. Down-regulation of HLA class Ⅰ antigen processing molecules: an immune escape mechanism of renal cell carcinoma[J]? J Urol, 2004,171(2 Pt 1):885
  • 7Seliger B, Atkins D, Bock M, et al. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transperter-associated with antigen-processing down-regulation[J]. Clin Cancer Res, 2003,9(5):1721
  • 8Wang Z, Cao Y, Albino AP, et al. Lack of HLA class Ⅰ antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-micmglobulin messenger RNA [J]. J Clin Invest, 1993,91(2):684
  • 9Hicklin DJ, Wang Z, Arienti F, et al. beta2-Microglobulin mutations, HLA class Ⅰ antigen loss, and tumor progression in melanoma[J]. J Clin Invest, 1998,101(12):2720
  • 10Sette A, Chesnut R, Fikes J. HLA expression in cancer: implications for T cell-based immunotherapy[J]. Immunogenetics, 2001,53 (4):225

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部